BeOne Medicines Ltd.
NASDAQ: ONC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- John V. Oyler
- Employees
- 11,000
- Headquarters
- United States
- IPO year
- 2016
- Market cap
- $28.9B
- Website
- https://beonemedicines.com
Loading ONC…
Loading profile data…Frequently asked questions about ONC
What does BeOne Medicines Ltd. (ONC) do?
BeOne Medicines Ltd. (ONC), initially founded in 2010 as BeiGene, stands as a prominent global oncology enterprise committed to identifying, advancing, and bringing to market cutting-edge cancer treatments. The company underwent a significant transformation, rebranding as BeOne in late 2024 and subsequently relocating its headquarters from Cambr...
Where does ONC trade?
BeOne Medicines Ltd. (ONC) trades on the NASDAQ Global Market.
What sector is ONC in?
BeOne Medicines Ltd. (ONC) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of BeOne Medicines Ltd.?
John V. Oyler is the chief executive officer of BeOne Medicines Ltd. (ONC).
Where is BeOne Medicines Ltd. headquartered?
BeOne Medicines Ltd. is headquartered in United States.
Does ONC pay a dividend?
BeOne Medicines Ltd. (ONC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ONC go public?
BeOne Medicines Ltd. (ONC) completed its initial public offering in 2016.
Is ONC an ADR?
Yes — ONC is an American Depositary Receipt; its underlying shares trade on a non-US exchange. BeOne Medicines Ltd. reporting and dividends follow the underlying issuer.